Institutional
Lion Point Capital, LP
CIK 0001643354
$16.7M
Reported AUM
35
Positions
Q1 2026
Period
2026-05-15
Filed
The Brief · Lion Point Capital, LP · Q1 2026
AI · grounded in 13F
Lion Point Capital, LP closed its position in Day One Biopharmaceuticals I DAWNGBX, reducing its holdings by $391,440. The fund also exited positions in Ventyx Biosciences Inc VTYXUSD for $374,745 and Minerva Neurosciences Inc NERV for $140,700. On the buy side, the fund increased its stake in Compass Pathways PLC CMPS by 37.931%.
Portfolio · Q1 2026
Top holdings
QoQ vs Q4 2025
| # | Ticker | Issuer | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|
| 1 | PRAX | PRAXIS PRECISION MEDICINES I | $1.4M | 8.57% | — | HELD |
| 2 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $1.3M | 7.52% | — | HELD |
| 3 | RPRX | ROYALTY PHARMA PLC | $1.0M | 6.14% | — | HELD |
| 4 | MIST | MILESTONE PHARMACEUTICALS IN | $976K | 5.83% | +65,000 | +8.6% |
| 5 | GERN | GERON CORP | $861K | 5.15% | — | HELD |
| 6 | SNDX | SYNDAX PHARMACEUTICALS INC | $841K | 5.03% | — | HELD |
| 7 | ARDX | ARDELYX INC | $771K | 4.61% | — | HELD |
| 8 | FENC | FENNEC PHARMACEUTICALS INC | $691K | 4.13% | — | HELD |
| 9 | BNTC | BENITEC BIOPHARMA INC | $660K | 3.95% | — | HELD |
| 10 | SRPT | SAREPTA THERAPEUTICS INC | $620K | 3.71% | — | HELD |
| 11 | IRON | DISC MEDICINE INC | $518K | 3.10% | — | HELD |
| 12 | CUE1EUR | CUE BIOPHARMA INC | $506K | 3.03% | — | HELD |
| 13 | CMPS | COMPASS PATHWAYS PLC | $442K | 2.64% | +22,000 | +37.9% |
| 14 | BHVN | BIOHAVEN LTD | $437K | 2.61% | — | HELD |
| 15 | LNTH | LANTHEUS HLDGS INC | $417K | 2.49% | — | HELD |
| 16 | JSPR | JASPER THERAPEUTICS INC | $407K | 2.44% | — | HELD |
| 17 | HUMA | HUMACYTE INC | $394K | 2.36% | +150,000 | +30.0% |
| 18 | VTRS | VIATRIS INC | $374K | 2.24% | — | HELD |
| 19 | KURA | KURA ONCOLOGY INC | $374K | 2.24% | — | HELD |
| 20 | BBIO | BRIDGEBIO PHARMA INC | $371K | 2.22% | — | HELD |
| 21 | DYN | DYNE THERAPEUTICS INC | $326K | 1.95% | — | HELD |
| 22 | RCKT | ROCKET PHARMACEUTICALS INC | $308K | 1.84% | — | HELD |
| 23 | PCRX | PACIRA BIOSCIENCES INC | $305K | 1.82% | — | HELD |
| 24 | EWTX | EDGEWISE THERAPEUTICS INC | $287K | 1.71% | — | HELD |
| 25 | MLYS | MINERALYS THERAPEUTICS INC | $284K | 1.70% | — | HELD |
| 26 | MCRB | SERES THERAPEUTICS INC | $280K | 1.67% | — | HELD |
| 27 | JANX | JANUX THERAPEUTICS INC | $264K | 1.58% | — | HELD |
| 28 | QURE | UNIQURE NV | $240K | 1.44% | — | HELD |
| 29 | RGNX | REGENXBIO INC | $223K | 1.33% | — | HELD |
| 30 | AZTA | AZENTA INC | $205K | 1.22% | — | HELD |
| 31 | INVA | INNOVIVA INC | $191K | 1.14% | — | HELD |
| 32 | GHRS | GH RESEARCH PLC | $143K | 0.86% | — | HELD |
| 33 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $124K | 0.74% | — | HELD |
| 34 | IPHA | INNATE PHARMA S A | $104K | 0.62% | — | HELD |
| 35 | SPRB | SPRUCE BIOSCIENCES INC | $65K | 0.39% | — | HELD |
| 36 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | — | — | -42,000 | EXITED |
| 37 | VTYXUSD | VENTYX BIOSCIENCES INC | — | — | -41,500 | EXITED |
| 38 | NERV | MINERVA NEUROSCIENCES INC | — | — | -35,000 | EXITED |
| 39 | MRSN | MERSANA THERAPEUTICS INC | — | — | -100 | EXITED |
Source: SEC EDGAR · accession 0001013594-26-000605. 13F discloses long positions only — shorts, foreign equities, and options are excluded.